Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Leukemia. 2017 Jul;31(7):1658. doi: 10.1038/leu.2017.77. Epub 2017 Mar 21.

Authors

W Fiskus, S Sharma, B Shah, B P Portier, S G T Devaraj, K Liu, S P Iyer, D Bearss, K N Bhalla

PMID: 28322226
DOI: 10.1038/leu.2017.77

Abstract

This corrects the article DOI: 10.1038/leu.2014.119.

Publication types

Published Erratum

Grants and funding